Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of share-based compensation expenses

Total share-based compensation expenses were as follows (in millions):

	For the Years Ended December 31,
	2024		2023		2022
Option awards	$	12.0	$	11.5	$	11.4
Other share-based awards	21.2		30.7		39.2
Total share-based compensation before tax	33.2		42.2		50.6
Tax benefit	8.1		10.3		12.0
Total share-based compensation expense included in net income	$	25.1	$	31.9	$	38.6

Schedule of stock option activity

The following summarizes stock option activity and the weighted-average exercise price for the Omnibus Plan for the year ended December 31, 2024:

	Omnibus Plan (Active)
	Options Outstanding	Weighted-Average Exercise Price
Balance as of December 31, 2023	2,825,985	$	107.75
Granted	386,055	89.96
Exercised	(21,868)	87.69
Forfeited/Expired	(504,921)	116.74
Balance as of December 31, 2024	2,685,251	$	103.66
Options exercisable as of December 31, 2024	2,141,073	$	104.48

Schedule of weighted average fair value

The following assumptions were used to estimate the weighted-average fair value of options granted of $31.79, $43.39 and $37.41 during the years ended December 31, 2024, 2023 and 2022, respectively:

	For the Years Ended December 31,
	2024	2023	2022
Weighted-average volatility	44%	45%	43%
Expected dividend yield	2.9%	2.2%	2.2%
Expected term (in years)	5.8	5.4	4.9
Weighted-average risk-free interest rate	3.9%	3.5%	1.7%

Schedule of restricted stock activity

The following table summarizes restricted stock activity for the year ended December 31, 2024:

	Shares Outstanding	Weighted-Average Grant Price
Balance as of December 31, 2023	805,189	$	118.42
Granted	510,768	107.33
Vested	(220,165)	105.30
Forfeited/Cancelled	(169,125)	116.58
Balance as of December 31, 2024	926,667	$	115.76
Expected to vest as of December 31, 2024	835,503	$	115.34